[The prevalence of abnormal glucose regulation after myocardial infarction: Comparative study in two French ethnic groups].

[1]  Y. Cottin,et al.  Impact of fasting glycemia on short-term prognosis after acute myocardial infarction. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  A. Dyer,et al.  Comparison of risk factors for cardiovascular mortality in black and white adults. , 2006, Archives of internal medicine.

[3]  G. Chatellier,et al.  Prevalence and therapeutic control of hypertension in French Caribbean regions , 2005, Journal of hypertension.

[4]  J Herlitz,et al.  Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.

[5]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[6]  P. McKeigue,et al.  Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study , 2005, Diabetologia.

[7]  W. Markiewicz,et al.  Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. , 2005, Circulation.

[8]  L. Rydén,et al.  Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. , 2004, European heart journal.

[9]  Roberto Ferrari,et al.  The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.

[10]  C. Wolfe,et al.  Ethnic Differences in Risk Factors for Ischemic Stroke: A European Case–Control Study , 2004, Stroke.

[11]  George Howard,et al.  Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study , 2004, Hypertension.

[12]  Y. Cottin,et al.  Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. , 2004, European heart journal.

[13]  J. Deloumeaux,et al.  Anthropometric parameters and type 2 diabetes: a case-control study in a Guadeloupean population. , 2004, Diabetes & metabolism.

[14]  Charles Maynard,et al.  Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. , 2003, Diabetes care.

[15]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[16]  L. Papoz.  Type 2 diabetes mellitus in the French overseas departments and territories: the "syndrome of Nauru". , 2002, Diabetes & metabolism.

[17]  J. Hanley,et al.  Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. , 2002, Journal of clinical epidemiology.

[18]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[19]  R. Holman,et al.  Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55). , 2001, Diabetes care.

[20]  D. Ekouevi,et al.  Lipid profile in an adult population in Guadeloupe. , 2000, Diabetes & metabolism.

[21]  A. Weill,et al.  [Epidemiology of diabetes in metropolitan France]. , 2000, Diabetes & metabolism.

[22]  A. Ergul,et al.  Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. , 2000, Hypertension.

[23]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[24]  P. McKeigue,et al.  Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. , 2000, Metabolism: clinical and experimental.

[25]  L. Clark,et al.  Primary prevention of cardiovascular disease in high-risk patients: physiologic and demographic risk factor differences between African American and white American populations. , 1999, The American journal of medicine.

[26]  K. Flegal,et al.  Racial and ethnic differences in glycemic control of adults with type 2 diabetes. , 1999, Diabetes care.

[27]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[28]  P. McKeigue,et al.  Cross sectional analysis of mortality by country of birth in england and wales, 1970-92 , 1997, BMJ.

[29]  J. Chesebro,et al.  Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.

[30]  R. Bergman,et al.  Insulin Sensitivity and Acute Insulin Response in African-Americans, Non-Hispanic Whites, and Hispanics With NIDDM: The Insulin Resistance Atherosclerosis Study , 1997, Diabetes.

[31]  B. Balkau,et al.  Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of African origin. , 1996, Revue d'epidemiologie et de sante publique.

[32]  J. Lovejoy,et al.  Abdominal fat distribution and metabolic risk factors: effects of race. , 1996, Metabolism: clinical and experimental.

[33]  N. Chaturvedi,et al.  Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans , 1994, Diabetologia.

[34]  A. Fontbonne,et al.  Features of Insulin-Resistance Syndrome in Men From French Caribbean Islands: The Telecom Study , 1992, Diabetes.

[35]  E. Eschwège,et al.  The prevalence of diabetes mellitus in the adult population of Guadeloupe as estimated by history or fasting hyperglycemia. , 1991, Diabetes research and clinical practice.

[36]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[37]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .